Transform Your Portfolio With This Simple Morning Trade!

Hi, I’m trading expert Dave Aquino and I want to show you how to take advantage of a trading opportunity happening nearly every morning at 9:30 EST.

My free guide, “How To Master The Retirement Trade” will show you exactly why traders in the know want to keep this trade a secret.

BCRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $2,931,932.75

BioCryst Pharmaceuticals Insider Trading History Chart

BioCryst Pharmaceuticals Share Price & Price History

^$7.35

▲ +0.19 (2.65%)

As of 09/22/2023 01:00 AM ET

Days: 30 | 90 | 365

Transform Your Portfolio With This Simple Morning Trade!

From Base Camp Trading | Ad

Claim your copy now!

BioCryst Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/15/2023	Machelle Sanders	Director	Sell	4,000	$7.98	$31,920.00	25,611
2/1/2023	Jon P. Stonehouse	CEO	Sell	100,000	$10.38	$1,038,000.00	1,008,739
12/15/2022	Anthony Doyle	CFO	Sell	5,700	$10.90	$62,130.00	163,966
12/15/2022	Helen M Thackray	Insider	Sell	3,125	$10.89	$34,031.25	133,275
12/15/2022	Jon P. Stonehouse	CEO	Sell	14,100	$10.90	$153,690.00	887,730
12/15/2022	Michael L Jones	Director	Sell	445	$10.90	$4,850.50	10,753
12/2/2022	Jon P. Stonehouse	CEO	Sell	82,656	$12.80	$1,057,996.80	901,830
12/1/2022	Michael L Jones	Director	Sell	8,600	$13.01	$111,886.00	11,198
11/14/2022	Yarlagadda S. Babu	Insider	Sell	31,515	$13.88	$437,428.20	298,541
4/1/2022	Helen M Thackray	Insider	Sell	7,600	$16.20	$123,120.00	136,400
2/15/2022	George B. Abercrombie	Director	Sell	5,000	$18.50	$92,500.00
1/11/2022	Jon P. Stonehouse	CEO	Sell	184,000	$15.04	$2,767,360.00
12/7/2021	Yarlagadda S. Babu	Insider	Sell	30,100	$12.20	$367,220.00
11/24/2021	Vincent Milano	Director	Buy	7,500	$12.19	$91,425.00
11/23/2021	Anthony Doyle	CFO	Buy	35,258	$12.48	$440,019.84
11/15/2021	George B. Abercrombie	Director	Sell	5,000	$12.27	$61,350.00
10/15/2021	Nancy J. Hutson	Director	Sell	105,000	$15.40	$1,617,000.00
9/10/2021	George B. Abercrombie	Director	Sell	74,000	$15.09	$1,116,660.00
7/15/2021	George B. Abercrombie	Director	Sell	5,000	$15.69	$78,450.00	8,000
5/27/2021	William P. Sheridan	Insider	Sell	71,759	$15.00	$1,076,385.00	39,434
5/24/2021	George B. Abercrombie	Director	Sell	6,667	$13.90	$92,671.30	9,667
5/10/2021	George B. Abercrombie	Director	Sell	7,000	$12.70	$88,900.00	3,000
12/11/2020	Alane P. Barnes	VP	Sell	13,741	$7.96	$109,378.36	121,802
12/4/2020	Alane P. Barnes	VP	Sell	13,741	$6.23	$85,606.43	121,802

Successful Options Trading Begins With…

From Tradewins | Ad

Options trading expert Wendy Kirkland’s free guide reveals the options trading principles that are as easy to implement as they are to learn and how using them could earn you thousands in extra income each month!

Download the guide here and see the difference!

SEC Filings (Institutional Ownership Changes) for BioCryst Pharmaceuticals (NASDAQ:BCRX)

91.46% of BioCryst Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BioCryst Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/22/2023	Virginia Retirement Systems ET AL	80,600	$0.57M	0.0%	N/A	0.043%
8/21/2023	California State Teachers Retirement System	228,878	$1.61M	0.0%	-1.7%	0.121%
8/21/2023	Osaic Holdings Inc.	603,089	$4.25M	0.0%	+7.3%	0.318%
8/16/2023	Nuveen Asset Management LLC	995,483	$7.01M	0.0%	+25.0%	0.525%
8/16/2023	GTS Securities LLC	18,300	$0.13M	0.0%	N/A	0.010%
8/15/2023	Wells Fargo & Company MN	255,681	$1.80M	0.0%	+39.0%	0.135%
8/15/2023	Public Employees Retirement System of Ohio	9,678	$68K	0.0%	-82.7%	0.005%
8/15/2023	Eventide Asset Management LLC	1,970,000	$13.87M	0.2%	+78.6%	1.040%
8/15/2023	XTX Topco Ltd	100,945	$0.71M	0.1%	+153.8%	0.053%
8/15/2023	Goldman Sachs Group Inc.	1,478,789	$10.41M	0.0%	+31.2%	0.780%
8/15/2023	Point72 Asset Management L.P.	4,004,700	$28.19M	0.1%	+7,385.4%	2.113%
8/15/2023	Point72 Middle East FZE	12,755	$90K	0.0%	-15.3%	0.007%
8/15/2023	Royal Bank of Canada	44,244	$0.31M	0.0%	-38.7%	0.023%
8/15/2023	Segall Bryant & Hamill LLC	2,037,688	$14.35M	0.2%	+10.9%	1.075%
8/15/2023	Silverarc Capital Management LLC	760,904	$5.36M	1.7%	+31.7%	0.402%
8/15/2023	HighVista Strategies LLC	68,725	$0.48M	0.2%	N/A	0.036%
8/15/2023	Hudson Bay Capital Management LP	64,700	$0.46M	0.0%	+52.2%	0.034%
8/15/2023	Kynam Capital Management LP	2,848,197	$20.05M	2.8%	+184.8%	1.503%
8/15/2023	Braidwell LP	2,791,880	$19.66M	0.6%	+43.5%	1.473%
8/15/2023	Bayesian Capital Management LP	15,000	$0.11M	0.0%	N/A	0.008%
8/15/2023	Bridgefront Capital LLC	20,302	$0.14M	0.1%	N/A	0.011%
8/14/2023	PDT Partners LLC	199,079	$1.40M	0.2%	+80.2%	0.105%
8/14/2023	Tudor Investment Corp Et Al	76,662	$0.54M	0.0%	N/A	0.040%
8/14/2023	Tower Research Capital LLC TRC	23,522	$0.17M	0.0%	+99.4%	0.012%
8/14/2023	Schonfeld Strategic Advisors LLC	121,137	$0.85M	0.0%	N/A	0.064%
8/14/2023	Bison Wealth LLC	151,015	$1.06M	0.2%	N/A	0.080%
8/14/2023	State of Wisconsin Investment Board	249,882	$1.76M	0.0%	+4.3%	0.132%
8/14/2023	State Street Corp	12,263,969	$86.34M	0.0%	+7.7%	6.472%
8/14/2023	Jefferies Financial Group Inc.	65,000	$0.46M	0.0%	N/A	0.034%
8/14/2023	Capital Fund Management S.A.	169,688	$1.20M	0.0%	+159.9%	0.090%
8/14/2023	Rock Springs Capital Management LP	2,497,193	$17.58M	0.4%	+7.0%	1.318%
8/14/2023	Nuveen Asset Management LLC	995,483	$7.01M	0.0%	+25.0%	0.525%
8/14/2023	Prosight Management LP	2,500,000	$17.60M	5.4%	+132.6%	1.319%
8/14/2023	Graham Capital Management L.P.	37,637	$0.27M	0.0%	N/A	0.020%
8/11/2023	Credit Suisse AG	282,017	$1.99M	0.0%	+8.0%	0.149%
8/11/2023	BlackRock Inc.	15,495,703	$109.09M	0.0%	+4.5%	8.178%
8/11/2023	Panagora Asset Management Inc.	685,509	$4.83M	0.0%	-0.9%	0.362%
8/11/2023	Kestra Advisory Services LLC	26,079	$0.18M	0.0%	+9.0%	0.014%
8/11/2023	The Manufacturers Life Insurance Company	76,926	$0.54M	0.0%	+3.4%	0.041%
8/11/2023	Trexquant Investment LP	335,518	$2.36M	0.1%	+188.3%	0.177%
8/11/2023	Guggenheim Capital LLC	113,556	$0.80M	0.0%	-11.7%	0.060%
8/11/2023	Geode Capital Management LLC	3,832,555	$26.98M	0.0%	+4.9%	2.023%
8/11/2023	Sei Investments Co.	26,995	$0.19M	0.0%	-37.9%	0.014%
8/11/2023	E Fund Management Co. Ltd.	52,423	$0.37M	0.0%	+12.5%	0.028%
8/11/2023	JPMorgan Chase & Co.	631,515	$4.45M	0.0%	+5.3%	0.333%
8/11/2023	PNC Financial Services Group Inc.	17,935	$0.13M	0.0%	+17.6%	0.009%
8/11/2023	Northern Trust Corp	1,837,521	$12.94M	0.0%	+4.2%	0.970%
8/11/2023	ExodusPoint Capital Management LP	1,212,547	$8.54M	0.1%	-0.7%	0.642%
8/10/2023	Osaic Holdings Inc.	603,089	$4.25M	0.0%	+7.3%	0.319%
8/10/2023	Great West Life Assurance Co. Can	41,931	$0.30M	0.0%	+9.2%	0.022%
8/10/2023	ProShare Advisors LLC	36,878	$0.26M	0.0%	+5.7%	0.020%
8/10/2023	Profund Advisors LLC	176,892	$1.25M	0.1%	+15.8%	0.094%
8/10/2023	Edgestream Partners L.P.	30,675	$0.22M	0.0%	N/A	0.016%
8/10/2023	Commonwealth Equity Services LLC	162,084	$1.14M	0.0%	+0.9%	0.086%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	122,146	$0.86M	0.0%	+1.6%	0.065%
8/10/2023	Russell Investments Group Ltd.	48,680	$0.34M	0.0%	-71.7%	0.026%
8/10/2023	Charles Schwab Investment Management Inc.	1,441,405	$10.15M	0.0%	+1.3%	0.763%
8/9/2023	BNP Paribas Arbitrage SNC	215,742	$1.52M	0.0%	-36.6%	0.114%
8/9/2023	Swiss National Bank	410,368	$2.89M	0.0%	+2.0%	0.217%
8/8/2023	Fisher Asset Management LLC	4,324,553	$30.44M	0.0%	+1.7%	2.289%
8/8/2023	Rhumbline Advisers	313,894	$2.21M	0.0%	+0.9%	0.166%
8/8/2023	AlphaCentric Advisors LLC	570,000	$4.01M	2.2%	+35.9%	0.302%
8/4/2023	American International Group Inc.	91,234	$0.64M	0.0%	+1.9%	0.048%
8/3/2023	Los Angeles Capital Management LLC	32,622	$0.23M	0.0%	N/A	0.017%
8/3/2023	Barclays PLC	549,739	$3.87M	0.0%	-21.8%	0.290%
8/3/2023	Mackenzie Financial Corp	52,082	$0.37M	0.0%	-11.5%	0.028%
8/3/2023	Bank of New York Mellon Corp	759,484	$5.35M	0.0%	+13.3%	0.402%
8/2/2023	Bank of Montreal Can	42,398	$0.33M	0.0%	N/A	0.022%
8/2/2023	State of New Jersey Common Pension Fund D	289,701	$2.04M	0.0%	+21.9%	0.153%
7/31/2023	Inspire Investing LLC	44,583	$0.31M	0.0%	+37.8%	0.024%
7/28/2023	First Republic Investment Management Inc.	29,294	$0.21M	0.0%	+147.5%	0.016%
7/27/2023	Empire Financial Management Company LLC	42,500	$0.30M	0.1%	+41.7%	0.022%
7/26/2023	Ballentine Partners LLC	10,951	$77K	0.0%	N/A	0.006%
7/26/2023	Janney Montgomery Scott LLC	26,877	$0.19M	0.0%	+24.3%	0.014%
7/25/2023	Assenagon Asset Management S.A.	5,332,914	$37.54M	0.1%	+7.3%	2.823%
7/24/2023	Rice Hall James & Associates LLC	1,872,964	$13.19M	0.7%	N/A	0.991%
7/19/2023	Teacher Retirement System of Texas	51,121	$0.36M	0.0%	-11.0%	0.027%
7/7/2023	Moody National Bank Trust Division	42,481	$0.30M	0.0%	+13.0%	0.022%
6/1/2023	Golden State Equity Partners	10,925	$91K	0.0%	N/A	0.006%
5/26/2023	ProShare Advisors LLC	34,897	$0.29M	0.0%	-11.2%	0.018%
5/22/2023	Putnam Investments LLC	39,479	$0.33M	0.0%	-4.0%	0.021%
5/22/2023	Arete Wealth Advisors LLC	23,973	$0.20M	0.0%	N/A	0.013%
5/22/2023	Ameriprise Financial Inc.	334,389	$2.79M	0.0%	-59.8%	0.177%
5/18/2023	JPMorgan Chase & Co.	599,817	$5M	0.0%	-39.4%	0.317%
5/18/2023	New York State Common Retirement Fund	207,093	$1.73M	0.0%	-14.8%	0.110%
5/17/2023	B. Riley Wealth Advisors Inc.	13,000	$0.11M	0.0%	N/A	0.007%
5/17/2023	Advisory Services Network LLC	4,740	$40K	0.0%	+46.3%	0.003%
5/16/2023	Hudson Bay Capital Management LP	42,500	$0.35M	0.0%	+70.0%	0.022%
5/16/2023	Segall Bryant & Hamill LLC	1,837,854	$15.33M	0.2%	+10.1%	0.973%
5/16/2023	State Street Corp	11,389,623	$94.99M	0.0%	+2.4%	6.028%
5/16/2023	Saturn V Capital Management LLC	1,163,535	$9.70M	7.2%	+242.1%	0.616%
5/16/2023	Squarepoint Ops LLC	150,775	$1.26M	0.0%	-45.7%	0.080%
5/16/2023	First Manhattan CO. LLC.	874,840	$7.30M	0.0%	-53.2%	0.463%
5/16/2023	First Trust Advisors LP	163,163	$1.36M	0.0%	-19.9%	0.086%
5/16/2023	Geode Capital Management LLC	3,653,556	$30.47M	0.0%	+5.4%	1.934%
5/16/2023	AQR Capital Management LLC	38,908	$0.32M	0.0%	+55.7%	0.021%
5/16/2023	Avoro Capital Advisors LLC	10,420,000	$86.90M	1.3%	+15.1%	5.515%
5/15/2023	Sarissa Capital Management LP	775,000	$6.46M	0.8%	-20.9%	0.410%
5/15/2023	Cubist Systematic Strategies LLC	452,615	$3.78M	0.0%	+34,319.4%	0.240%
5/15/2023	Braidwell LP	1,945,134	$16.22M	0.5%	N/A	1.030%

Data available starting January 2016

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor for complement-mediated diseases; and Galidesivir, to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

Today's Range

Now: $7.35

$7.07

$7.37

50 Day Range

MA: $7.18

$6.71

$7.92

52 Week Range

Now: $7.35

$6.62

$14.50

Volume

1,949,900 shs

Average Volume

2,371,139 shs

Market Capitalization

$1.39 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.88

Who are the company insiders with the largest holdings of BioCryst Pharmaceuticals?: BioCryst Pharmaceuticals' top insider shareholders include:
Jon P Stonehouse (CEO)
Yarlagadda S Babu (Insider)
Anthony Doyle (CFO)
Helen M Thackray (Insider)
Machelle Sanders (Director)
Michael L Jones (Director)
George B Abercrombie (Director)
Nancy J Hutson (Director)
Vincent Milano (Director)
Learn More about top insider investors at BioCryst Pharmaceuticals.
Who are the major institutional investors of BioCryst Pharmaceuticals?: BioCryst Pharmaceuticals' top institutional shareholders include:
BlackRock Inc. — 8.18%
State Street Corp — 6.47%
Assenagon Asset Management S.A. — 2.82%
Fisher Asset Management LLC — 2.29%
Point72 Asset Management L.P. — 2.11%
Geode Capital Management LLC — 2.02%
Learn More about top institutional investors of BioCryst Pharmaceuticals stock.
Which major investors are selling BioCryst Pharmaceuticals stock?: During the last quarter, BCRX stock was sold by these institutional investors:
Barclays PLC
BNP Paribas Arbitrage SNC
Russell Investments Group Ltd.
Simplex Trading LLC
Public Employees Retirement System of Ohio
Caption Management LLC
Citadel Advisors LLC
Royal Bank of Canada
Within the previous year, company insiders that have sold BioCryst Pharmaceuticals company stock include:
Jon P Stonehouse (CEO)
Yarlagadda S Babu (Insider)
Anthony Doyle (CFO)
Helen M Thackray (Insider)
Machelle Sanders (Director)
Michael L Jones (Director)
Learn More investors selling BioCryst Pharmaceuticals stock.
Which major investors are buying BioCryst Pharmaceuticals stock?: Within the previous quarter, BCRX stock was bought by institutional investors including:
Point72 Asset Management L.P.
Rice Hall James & Associates LLC
Kynam Capital Management LP
Prosight Management LP
State Street Corp
Eventide Asset Management LLC
Braidwell LP
BlackRock Inc.
In the previous year, these company insiders have bought BioCryst Pharmaceuticals stock:
Jon P Stonehouse (CEO)
Yarlagadda S Babu (Insider)
Learn More investors buying BioCryst Pharmaceuticals stock.

Transform Your Portfolio With This Simple Morning Trade!

From Base Camp Trading | Ad

Claim your copy now!

BCRX Insider Trading

BioCryst Pharmaceuticals Insider Trading History Chart

BioCryst Pharmaceuticals Share Price & Price History

BioCryst Pharmaceuticals Insider Trading History

SEC Filings (Institutional Ownership Changes) for BioCryst Pharmaceuticals (NASDAQ:BCRX)

Institutional Buying and Selling by Quarter

BioCryst Pharmaceuticals Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of BioCryst Pharmaceuticals?

Who are the major institutional investors of BioCryst Pharmaceuticals?

Which major investors are selling BioCryst Pharmaceuticals stock?

Which major investors are buying BioCryst Pharmaceuticals stock?